|
Volumn 121, Issue 3, 2008, Pages 598-600
|
Asthma progression: Can we and should we measure it?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLERGEN;
CORTICOSTEROID;
CYTOKINE;
GELATINASE B;
IMMUNOMODULATING AGENT;
METALLOPROTEINASE;
PROTEIN ADAM 33;
TRANSFORMING GROWTH FACTOR BETA;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
ASTHMA;
DISEASE CONTROL;
DISEASE COURSE;
DISEASE SEVERITY;
EDITORIAL;
FORCED EXPIRATORY VOLUME;
GENETIC ANALYSIS;
HUMAN;
INFLAMMATION;
LUNG FUNCTION;
NONHUMAN;
PATHOGENESIS;
PHENOTYPE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
RISK ASSESSMENT;
TH2 CELL;
TISSUE REPAIR;
WHEEZING;
|
EID: 40249111498
PISSN: 00916749
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaci.2007.12.1192 Document Type: Editorial |
Times cited : (5)
|
References (9)
|